BRPI0606142A2 - agonistas de pyy e usos dos mesmos - Google Patents

agonistas de pyy e usos dos mesmos

Info

Publication number
BRPI0606142A2
BRPI0606142A2 BRPI0606142-7A BRPI0606142A BRPI0606142A2 BR PI0606142 A2 BRPI0606142 A2 BR PI0606142A2 BR PI0606142 A BRPI0606142 A BR PI0606142A BR PI0606142 A2 BRPI0606142 A2 BR PI0606142A2
Authority
BR
Brazil
Prior art keywords
pyy agonists
pyy
agonists
pyy336
npy
Prior art date
Application number
BRPI0606142-7A
Other languages
English (en)
Inventor
Rory Francis Finn
Ned Roger Siegel
Neena Lynne Summers
Nancy Ann Nardone
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0606142A2 publication Critical patent/BRPI0606142A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

AGONISTAS DE PYY E USOS DOS MESMOS. A presente invenção refere-se às variantes de PYY336 e derivados peguilados dos mesmos e composições e métodos úteis no tratamento de condições moduladas por um agonista de receptor de NPY Y2.
BRPI0606142-7A 2005-02-04 2006-01-30 agonistas de pyy e usos dos mesmos BRPI0606142A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65036605P 2005-02-04 2005-02-04
US73365605P 2005-11-04 2005-11-04
PCT/IB2006/000270 WO2006082517A1 (en) 2005-02-04 2006-01-30 Pyy agonists and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0606142A2 true BRPI0606142A2 (pt) 2009-06-02

Family

ID=36175074

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606142-7A BRPI0606142A2 (pt) 2005-02-04 2006-01-30 agonistas de pyy e usos dos mesmos

Country Status (33)

Country Link
US (3) US20060178501A1 (pt)
EP (2) EP2078729A1 (pt)
JP (1) JP4314304B2 (pt)
KR (1) KR100892545B1 (pt)
AP (1) AP2007004069A0 (pt)
AR (1) AR052108A1 (pt)
AT (1) ATE426614T1 (pt)
AU (1) AU2006211039A1 (pt)
BR (1) BRPI0606142A2 (pt)
CA (1) CA2596977C (pt)
CY (1) CY1109054T1 (pt)
DE (1) DE602006005902D1 (pt)
DK (1) DK1846445T3 (pt)
DO (1) DOP2006000025A (pt)
EA (1) EA011882B1 (pt)
ES (1) ES2322293T3 (pt)
GT (1) GT200600038A (pt)
HR (1) HRP20090245T1 (pt)
IL (1) IL184324A0 (pt)
MA (1) MA29243B1 (pt)
MX (1) MX2007009389A (pt)
NL (2) NL1031067C2 (pt)
NO (1) NO20074498L (pt)
PA (1) PA8660701A1 (pt)
PE (1) PE20061412A1 (pt)
PL (1) PL1846445T3 (pt)
PT (1) PT1846445E (pt)
RS (1) RS50966B (pt)
SI (1) SI1846445T1 (pt)
TN (1) TNSN07305A1 (pt)
TW (1) TWI310038B (pt)
UY (1) UY29357A1 (pt)
WO (1) WO2006082517A1 (pt)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002332054B2 (en) 2001-09-24 2007-11-08 Imperial Innovations Limited Modification of feeding behavior
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
AU2004236174B2 (en) 2001-10-10 2011-06-02 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
ES2560657T3 (es) 2004-01-08 2016-02-22 Ratiopharm Gmbh Glicosilación con unión en O de péptidos G-CSF
MXPA06010764A (es) * 2004-03-23 2006-12-15 Amgen Inc Metodos y composiciones de proteinas quimicamente modificadas.
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
DK2586456T3 (en) 2004-10-29 2016-03-21 Ratiopharm Gmbh Conversion and glycopegylation of fibroblast growth factor (FGF)
EP1858543B1 (en) 2005-01-10 2013-11-27 BioGeneriX AG Glycopegylated granulocyte colony stimulating factor
EP2386571B1 (en) 2005-04-08 2016-06-01 ratiopharm GmbH Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20090042790A1 (en) * 2005-06-13 2009-02-12 Nastech Pharmaceutical Company Inc. Transmucosal delivery of peptide derivatives
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
EP2380435B1 (en) * 2005-08-31 2016-05-25 Kaneka Corporation Feline-derived erythropoietin and method for production thereof
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
WO2007085887A1 (en) * 2006-01-27 2007-08-02 Pfizer Products Inc. Pyy agonists and uses thereof
EP2049144B8 (en) 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylation of peptides via o-linked glycosylation sequences
JP2008069073A (ja) * 2006-09-12 2008-03-27 Yokohama Tlo Co Ltd ラクトフェリン複合体及びその製造方法
US20100075375A1 (en) 2006-10-03 2010-03-25 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
LT2068907T (lt) * 2006-10-04 2018-01-10 Novo Nordisk A/S Glicerolio sujungti pegilinti sacharidai ir glikopeptidai
TWI428346B (zh) 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
CN101796063B (zh) 2007-04-03 2017-03-22 拉蒂奥法姆有限责任公司 使用糖聚乙二醇化g‑csf的治疗方法
ES2551123T3 (es) 2007-06-12 2015-11-16 Ratiopharm Gmbh Proceso mejorado para la producción de azúcares de nucleótido
MX2010009154A (es) 2008-02-27 2010-09-09 Novo Nordisk As Moleculas conjugadas del factor viii.
WO2010016936A1 (en) * 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide
EA201170647A1 (ru) * 2008-11-04 2011-12-30 Янссен Фармацевтика Нв Пептиды-агонисты crhr2 и их использование
WO2010067233A1 (en) 2008-12-08 2010-06-17 Pfizer Inc. 1,2,4 triazolo [4, 3 -a] [1,5] benzodiazepin-5 (6h) -ones as agonists of the cholecystokinin-1 receptor (cck-ir)
CA2748587A1 (en) 2009-01-20 2010-07-29 Pfizer Inc. Substituted pyrazinone amides
WO2010086820A1 (en) 2009-02-02 2010-08-05 Pfizer Inc. 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
TW201040174A (en) 2009-02-03 2010-11-16 Pfizer 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6H)-one derivatives
JP2012516885A (ja) 2009-02-04 2012-07-26 ファイザー・インク ４−アミノ−７，８−ジヒドロピリド［４，３−ｄ］ピリミジン−５（６Ｈ）−オン誘導体
EP2406253B1 (en) 2009-03-11 2013-07-03 Pfizer Inc. Benzofuranyl derivatives used as glucokinase inhibitors
CA2754685A1 (en) 2009-03-11 2010-09-16 Pfizer Inc. Substituted indazole amides
CA2754523A1 (en) 2009-03-20 2010-09-23 Pfizer Inc. 3-oxa-7-azabicyclo[3.3.1]nonanes
AU2010255422B2 (en) 2009-06-05 2014-04-10 Pfizer Inc. 1- ( piperidin-4-yl) -pyrazole derivatives as GPR 119 modulators
CA2772188A1 (en) 2009-09-23 2011-03-31 Pfizer Inc. Gpr 119 modulators
JP5696156B2 (ja) 2009-11-02 2015-04-08 ファイザー・インク ジオキサ−ビシクロ［３．２．１］オクタン−２，３，４−トリオール誘導体
AP3283A (en) 2009-11-10 2015-05-31 Pfizer N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
EP2499140A1 (en) 2009-11-10 2012-09-19 Pfizer Inc. N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
WO2011061679A1 (en) 2009-11-23 2011-05-26 Pfizer Inc. Imidazo-pyrazoles as gpr119 inhibitors
PT2547679E (pt) 2010-03-19 2016-01-27 Pfizer Derivados de 2,3-di-hidro-1h-indeno-1-il-2,7-diazaspiro[3.6]nonano e sua utilização como antagonistas ou agonistas inversos do receptor de grelina
WO2011158149A1 (en) 2010-06-18 2011-12-22 Pfizer Inc. 2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one derivatives
CA2811033C (en) 2010-09-30 2015-10-20 Pfizer Inc. N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
KR20150006899A (ko) 2010-10-29 2015-01-19 화이자 인코포레이티드 N1/N2-락탐 아세틸-CoA 카복실라아제 억제제
MX2013006768A (es) 2010-12-23 2013-07-22 Pfizer Moduladores de receptor de glucagon.
DK2673260T3 (en) 2011-02-08 2016-10-10 Pfizer Glucagonreceptormodulator
ME02312B (me) 2011-04-22 2016-06-20 Pfizer DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE
WO2013011402A1 (en) 2011-07-15 2013-01-24 Pfizer Inc. Gpr 119 modulators
EP2734503B1 (en) 2011-07-22 2015-09-16 Pfizer Inc. Quinolinyl glucagon receptor modulators
ES2605565T3 (es) 2011-08-31 2017-03-15 Pfizer Inc Compuestos de hexahidropirano [3,4-D][1,3]tiazin-2-amina
KR101541764B1 (ko) 2012-02-24 2015-08-05 (주)알테오젠 시스테인 잔기를 포함하는 모티프가 결합된 변형항체, 상기 변형항체를 포함하는 변형항체-약물 접합체 및 그 제조방법
KR20140137404A (ko) 2012-04-06 2014-12-02 화이자 인코포레이티드 디아실글리세롤 아실트랜스퍼라제 2 억제제
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
ES2585262T3 (es) 2012-05-04 2016-10-04 Pfizer Inc Compuestos heterocíclicos de hexahidropiran[3,4-d][1,3]tiazin-2-amina sustituidos como inhibidores de PPA, BACE1 y BACE2
EP2897964A1 (en) 2012-09-20 2015-07-29 Pfizer Inc. Alkyl-substituted hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
CA2893256A1 (en) 2012-12-11 2014-06-19 Pfizer Inc. Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
WO2014097038A1 (en) 2012-12-19 2014-06-26 Pfizer Inc. CARBOCYCLIC- AND HETEROCYCLIC-SUBSTITUTED HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS
WO2014125394A1 (en) 2013-02-13 2014-08-21 Pfizer Inc. HETEROARYL-SUBSTITUTED HEXAHYDROPYRANO [3,4-d][1,3] THIAZIN-2-AMINE COMPOUNDS
US9233981B1 (en) 2013-02-15 2016-01-12 Pfizer Inc. Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
BR112015027528B1 (pt) 2013-05-02 2023-02-14 Glaxosmithkline Intellectual Property Development Limited Polipeptídeo, forma de sal, combinação farmacêutica e composição farmacêutica
CA2926568C (en) 2013-10-09 2017-09-05 Pfizer Inc. Antagonists of prostaglandin ep3 receptor
BR112016012325A2 (pt) * 2013-12-20 2017-09-26 Hoffmann La Roche métodos para amidação c-terminal in vivo de um polipeptídeo e para a produção recombinante de um polipeptídeo e uso de uma peptidilglicina
DK3119757T3 (en) 2014-03-17 2018-06-18 Pfizer DIACYLGYLERIC-ACYL TRANSFERASE-2 INHIBITORS TO USE IN THE TREATMENT OF METABOLIC AND RELATED DISEASES
AP2016009493A0 (en) 2014-04-10 2016-10-31 Pfizer 2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES
WO2016092413A1 (en) 2014-12-10 2016-06-16 Pfizer Inc. Indole and indazole compounds that activate ampk
JP2017538769A (ja) 2014-12-22 2017-12-28 ファイザー・インク プロスタグランジンｅｐ３受容体の拮抗薬
WO2016124687A1 (en) * 2015-02-04 2016-08-11 Novo Nordisk A/S Selective pyy compounds and uses thereof
KR102426986B1 (ko) 2015-06-17 2022-07-28 화이자 인코포레이티드 삼환형 화합물 및 포스포다이에스터라제 억제제로서 이의 용도
EP3353183A1 (en) 2015-09-24 2018-08-01 Pfizer Inc N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3]thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl]amides
JP2018534251A (ja) 2015-09-24 2018-11-22 ファイザー・インク Ｂａｃｅ阻害剤として有用なｎ−［２−（３−アミノ−２，５−ジメチル−１，１−ジオキシド−５，６−ジヒドロ−２ｈ−１，２，４−チアジアジン−５−イル）−１，３−チアゾール−４−イル］アミド
JP2018531924A (ja) 2015-09-24 2018-11-01 ファイザー・インク テトラヒドロピラノ［３，４−ｄ］［１，３］オキサジン誘導体、およびｂａｃｅ阻害剤としてのその使用
SG11201804363UA (en) 2015-12-29 2018-07-30 Pfizer Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
AR109179A1 (es) 2016-08-19 2018-11-07 Pfizer Inhibidores de diacilglicerol aciltransferasa 2
WO2019106193A1 (en) 2017-12-01 2019-06-06 University Of Copenhagen Peptide hormone with one or more o-glycans
US20210231658A1 (en) * 2018-04-26 2021-07-29 Colorado State University Research Foundation Methods and Compositions for Tracking Vegetation
CR20210110A (es) 2018-08-31 2021-05-13 Pfizer Combinaciones para tratamiento de ehna/ehgna y enfermedades relacionadas
CA3140972C (en) 2019-05-20 2024-06-18 Pfizer Inc. Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
EP4366755A1 (en) * 2021-07-08 2024-05-15 Gila Therapeutics, Inc. Compositions and methods for activating a neural receptor
WO2023026180A1 (en) 2021-08-26 2023-03-02 Pfizer Inc. Amorphous form of (s)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-n-(tetrahydrofuran-3- yl)pyrimidine-5-carboxamide
WO2024118524A1 (en) 2022-11-28 2024-06-06 Cerevel Therapeutics, Llc Azaindole compounds and their use as phosphodiesterase inhibitors

Family Cites Families (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US176630A (en) * 1876-04-25 Improvement in wagon-locks
US176643A (en) * 1876-04-25 Improvement in ironing-tables
US244041A (en) * 1881-07-12 Machine for blocking and shaping hats
US141985A (en) * 1873-08-19 Improvement in sewing-machine tables
US2919901A (en) * 1957-01-25 1960-01-05 Thor Power Tool Co Drill system with suction
US4908713A (en) * 1981-12-14 1990-03-13 Levine Michael R VCR Programmer
US5508815A (en) * 1981-12-14 1996-04-16 Smart Vcr Limited Partnership Schedule display system for video recorder programming
US4586158A (en) * 1983-02-22 1986-04-29 International Business Machines Corp. Screen management system
US6319685B1 (en) 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
US4708934A (en) 1984-09-27 1987-11-24 Unigene Laboratories, Inc. α-amidation enzyme
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
DE3590766T (pt) 1985-03-30 1987-04-23
US4821097A (en) * 1987-03-05 1989-04-11 General Instrument Corporation Apparatus and method for providing digital audio on the sound carrier of a standard television signal
US5789234A (en) 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US4930158A (en) * 1987-09-02 1990-05-29 Vogel Peter S Selective video playing system
US4984152A (en) * 1987-10-06 1991-01-08 Bell Communications Research, Inc. System for controlling computer processing utilizing a multifunctional cursor with decoupling of pointer and image functionalities in space and time
US4827250A (en) * 1987-10-26 1989-05-02 Tektronix, Inc. Graphics display system having data transform circuit
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US4991011A (en) * 1988-12-23 1991-02-05 Scientific-Atlanta, Inc. Interactive television terminal with programmable background audio or video
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
AU648505B2 (en) 1989-05-19 1994-04-28 Amgen, Inc. Metalloproteinase inhibitor
US5727060A (en) * 1989-10-30 1998-03-10 Starsight Telecast, Inc. Television schedule system
JP3068180B2 (ja) 1990-01-12 2000-07-24 アブジェニックス インコーポレイテッド 異種抗体の生成
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5293357A (en) * 1990-09-10 1994-03-08 The Superguide Corporation Method and apparatus for controlling a television program recording device
US5247347A (en) * 1991-09-27 1993-09-21 Bell Atlantic Network Services, Inc. Pstn architecture for video-on-demand services
JP2654283B2 (ja) * 1991-09-30 1997-09-17 株式会社東芝 アイコン表示方法
US5317391A (en) * 1991-11-29 1994-05-31 Scientific-Atlanta, Inc. Method and apparatus for providing message information to subscribers in a cable television system
US5291554A (en) * 1992-05-28 1994-03-01 Tv Answer, Inc. Shared-price custom video rentals via interactive TV
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
JPH06139671A (ja) * 1992-10-27 1994-05-20 Sony Corp 記録再生システム
US5628864A (en) * 1992-10-30 1997-05-13 Juki Corporation Cutting unit in automatic enclosing and sealing apparatus
US5592551A (en) * 1992-12-01 1997-01-07 Scientific-Atlanta, Inc. Method and apparatus for providing interactive electronic programming guide
US5715515A (en) * 1992-12-02 1998-02-03 Scientific-Atlanta, Inc. Method and apparatus for downloading on-screen graphics and captions to a television terminal
US5410326A (en) * 1992-12-04 1995-04-25 Goldstein; Steven W. Programmable remote control device for interacting with a plurality of remotely controlled devices
EP0920207B2 (en) * 1992-12-09 2006-09-27 Sedna Patent Services, LLC Interactive terminal for television delivery system
US5600364A (en) * 1992-12-09 1997-02-04 Discovery Communications, Inc. Network controller for cable television delivery systems
US5483277A (en) * 1992-12-15 1996-01-09 Alcatel Network Systems Simplified set-top converter for broadband switched network
US5598524A (en) * 1993-03-03 1997-01-28 Apple Computer, Inc. Method and apparatus for improved manipulation of data between an application program and the files system on a computer-controlled display system
NZ265452A (en) * 1993-03-29 1997-09-22 Univ Cincinnati Analogues of peptide yy, dimers and pharmaceutical compositions
US5621456A (en) * 1993-06-22 1997-04-15 Apple Computer, Inc. Methods and apparatus for audio-visual interface for the display of multiple program categories
US5594509A (en) * 1993-06-22 1997-01-14 Apple Computer, Inc. Method and apparatus for audio-visual interface for the display of multiple levels of information on a display
US5414455A (en) * 1993-07-07 1995-05-09 Digital Equipment Corporation Segmented video on demand system
US5410344A (en) * 1993-09-22 1995-04-25 Arrowsmith Technologies, Inc. Apparatus and method of selecting video programs based on viewers' preferences
US5398071A (en) * 1993-11-02 1995-03-14 Texas Instruments Incorporated Film-to-video format detection for digital television
US5481542A (en) * 1993-11-10 1996-01-02 Scientific-Atlanta, Inc. Interactive information services control system
US5422674A (en) * 1993-12-22 1995-06-06 Digital Equipment Corporation Remote display of an image by transmitting compressed video frames representing background and overlay portions thereof
US5516653A (en) * 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
JPH07244781A (ja) * 1994-03-07 1995-09-19 C S K Sogo Kenkyusho:Kk ソフトウェアレンタル方法および装置ならびに流通媒体
US5629732A (en) * 1994-03-29 1997-05-13 The Trustees Of Columbia University In The City Of New York Viewer controllable on-demand multimedia service
US5512958A (en) * 1994-04-29 1996-04-30 Matsushita Electric Corporation Of America System for controlling the effects of noise in television receivers
US5521631A (en) * 1994-05-25 1996-05-28 Spectravision, Inc. Interactive digital video services system with store and forward capabilities
JP3575063B2 (ja) * 1994-07-04 2004-10-06 ソニー株式会社 再生装置、再生方法
US5596106A (en) 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists
DE69521374T2 (de) * 1994-08-24 2001-10-11 Hyundai Electronics America, Milpitas Videoserver und diesen verwendendes System
US5682325A (en) * 1994-09-12 1997-10-28 Bell Atlantic Network Services, Inc. Level 1 gateway for video tone networks
US5619249A (en) * 1994-09-14 1997-04-08 Time Warner Entertainment Company, L.P. Telecasting service for providing video programs on demand with an interactive interface for facilitating viewer selection of video programs
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US5614940A (en) * 1994-10-21 1997-03-25 Intel Corporation Method and apparatus for providing broadcast information with indexing
CZ286476B6 (en) 1994-10-27 2000-04-12 Janssen Pharmaceutica Nv Heteroaryl substituted derivatives of 1,3-dioxolan-4-ylmethoxyphenyl-1-piperazinylphenyl-2,4-dihydro-2-alkyl-3H-1,2,4-triazol-3-one, process and intermediates for their preparation and pharmaceutical preparations containing thereof
US5521186A (en) 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors
US5724521A (en) * 1994-11-03 1998-03-03 Intel Corporation Method and apparatus for providing electronic advertisements to end users in a consumer best-fit pricing manner
US5623613A (en) * 1994-11-29 1997-04-22 Microsoft Corporation System for displaying programming information
US5912227A (en) * 1995-01-27 1999-06-15 North Carolina State University Method of enhancing nutrient uptake
US5619247A (en) * 1995-02-24 1997-04-08 Smart Vcr Limited Partnership Stored program pay-per-play
US5632681A (en) * 1995-03-07 1997-05-27 International Business Machines Corporation Universal electronic video game renting/distributing system
US5651010A (en) * 1995-03-16 1997-07-22 Bell Atlantic Network Services, Inc. Simultaneous overlapping broadcasting of digital programs
DE69637481T2 (de) 1995-04-27 2009-04-09 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
US5721829A (en) * 1995-05-05 1998-02-24 Microsoft Corporation System for automatic pause/resume of content delivered on a channel in response to switching to and from that channel and resuming so that a portion of the content is repeated
US6558708B1 (en) * 1995-05-17 2003-05-06 Cedars-Sinai Medical Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
US5740549A (en) * 1995-06-12 1998-04-14 Pointcast, Inc. Information and advertising distribution system and method
US5751282A (en) * 1995-06-13 1998-05-12 Microsoft Corporation System and method for calling video on demand using an electronic programming guide
US5724106A (en) * 1995-07-17 1998-03-03 Gateway 2000, Inc. Hand held remote control device with trigger button
US5745837A (en) * 1995-08-25 1998-04-28 Terayon Corporation Apparatus and method for digital data transmission over a CATV system using an ATM transport protocol and SCDMA
US5737028A (en) * 1995-11-01 1998-04-07 International Business Machines Corporation Previous channel listing with cursor controlled user interface for television video displays
US5919901A (en) * 1996-04-08 1999-07-06 Bayer Corporation Neuropeptide Y receptor Y5 and nucleic acid sequences
US5721897A (en) * 1996-04-09 1998-02-24 Rubinstein; Seymour I. Browse by prompted keyword phrases with an improved user interface
US5721827A (en) * 1996-10-02 1998-02-24 James Logan System for electrically distributing personalized information
US6654933B1 (en) * 1999-09-21 2003-11-25 Kasenna, Inc. System and method for media stream indexing
ES2375330T3 (es) 1997-04-16 2012-02-28 Unigene Laboratories, Inc. Expresión directa de péptidos en medios de cultivo.
IL121230A (en) * 1997-07-03 2004-05-12 Nds Ltd Intelligent electronic program guide
US6342220B1 (en) 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
US20020026496A1 (en) * 1997-09-18 2002-02-28 Franklin E. Boyer Electronic-mail reminder for an internet television program guide
DE69841723D1 (de) 1997-09-26 2010-07-29 Abt Holding Co Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna
US6046167A (en) * 1998-03-25 2000-04-04 University Of Cincinnati Peptide YY analogs
US6505348B1 (en) * 1998-07-29 2003-01-07 Starsight Telecast, Inc. Multiple interactive electronic program guide system and methods
US6360053B1 (en) * 1998-08-07 2002-03-19 Replaytv, Inc. Method and apparatus for fast forwarding and rewinding in a video recording device
IL141769A0 (en) 1998-09-11 2002-03-10 Aventis Pharma Sa Azetidine derivatives, preparation and medicines containing them
US20020026638A1 (en) * 2000-08-31 2002-02-28 Eldering Charles A. Internet-based electronic program guide advertisement insertion method and apparatus
FR2789079B3 (fr) 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
ES2353728T3 (es) * 1999-02-10 2011-03-04 Curis, Inc. Péptido yy (pyy) para tratar trastornos metabólicos de la glucosa.
US7086077B2 (en) * 1999-04-01 2006-08-01 Sedna Patent Services, Llc Service rate change method and apparatus
US7010801B1 (en) * 1999-06-11 2006-03-07 Scientific-Atlanta, Inc. Video on demand system with parameter-controlled bandwidth deallocation
US6832386B1 (en) * 1999-06-11 2004-12-14 Scientific-Atlanta, Inc. System and method for allowing a user to quickly navigate within a program guide to an established reference point
US6986156B1 (en) * 1999-06-11 2006-01-10 Scientific Atlanta, Inc Systems and methods for adaptive scheduling and dynamic bandwidth resource allocation management in a digital broadband delivery system
US7150031B1 (en) * 2000-06-09 2006-12-12 Scientific-Atlanta, Inc. System and method for reminders of upcoming rentable media offerings
US7228556B2 (en) * 1999-12-21 2007-06-05 Tivo Inc. Distributed, interactive television program guide; system and method
US20030030679A1 (en) * 2000-01-06 2003-02-13 Anuj Kumar Jain User-definable images in bookmarks
AU2001247901B2 (en) * 2000-03-31 2006-07-27 Rovi Guides, Inc. Interactive media system and method for presenting pause-time content
AU2001253042A1 (en) * 2000-03-31 2001-10-15 Liquid Engines, Inc. System and method for implementing electronic markets
US20020007485A1 (en) * 2000-04-03 2002-01-17 Rodriguez Arturo A. Television service enhancements
GB0008691D0 (en) * 2000-04-07 2000-05-31 Post Impressions Systems Ltd Input and output systems for data processing
US7934232B1 (en) * 2000-05-04 2011-04-26 Jerding Dean F Navigation paradigm for access to television services
US8069259B2 (en) * 2000-06-09 2011-11-29 Rodriguez Arturo A Managing removal of media titles from a list
US7685520B2 (en) * 2000-06-22 2010-03-23 Intel Corporation Electronic programming guide with selectable categories
US7962370B2 (en) * 2000-06-29 2011-06-14 Rodriguez Arturo A Methods in a media service system for transaction processing
JP4356226B2 (ja) * 2000-09-12 2009-11-04 ソニー株式会社 サーバ装置、配信システム、配信方法、及び端末装置
US8302127B2 (en) * 2000-09-25 2012-10-30 Thomson Licensing System and method for personalized TV
KR20030038804A (ko) * 2000-10-11 2003-05-16 유나이티드 비디오 프로퍼티즈, 인크. 사용자 매체 리스트 구축 시스템 및 방법
US20020049978A1 (en) * 2000-10-20 2002-04-25 Rodriguez Arturo A. System and method for access and placement of media content information items on a screen display with a remote control device
US6924291B2 (en) 2001-01-23 2005-08-02 Merck & Co., Inc. Process for making spiro isobenzofuranone compounds
AR033046A1 (es) 2001-03-22 2003-12-03 Solvay Pharm Bv Derivados de 4,5-dihidro-1h-pirazol que tienen actividad antagonista de cb1, composicion farmaceutica y metodos de preparacion
AU2002303431C1 (en) 2001-04-19 2008-03-06 The Regents Of The University Of California Methods and composition for the production of orthoganal tRNA-aminoacyltRNA synthetase pairs
CN1522246B (zh) 2001-06-28 2010-04-21 辉瑞产品公司 三酰胺取代的吲哚、苯并呋喃及苯并噻吩
US8006262B2 (en) * 2001-06-29 2011-08-23 Rodriguez Arturo A Graphic user interfaces for purchasable and recordable media (PRM) downloads
AU2002332054B2 (en) * 2001-09-24 2007-11-08 Imperial Innovations Limited Modification of feeding behavior
US7142590B2 (en) * 2001-10-11 2006-11-28 Utstarcom Inc. Method and system for oversubscribing a DSL modem
US20030074257A1 (en) * 2001-10-12 2003-04-17 Michael Saveliev Method and apparatus for advertising adjacent to a beverage dispenser to facilitate advertising income device placement in high traffic venues
US7334251B2 (en) * 2002-02-11 2008-02-19 Scientific-Atlanta, Inc. Management of television advertising
AU2003219934A1 (en) 2002-03-06 2003-09-22 Merck And Co., Inc. Method of treatment or prevention of obesity
JP2005528366A (ja) 2002-03-26 2005-09-22 メルク　エンド　カムパニー　インコーポレーテッド カンナビノイド受容体モジュレータとしてのスピロ環式アミド
AU2003250117B2 (en) 2002-07-29 2007-05-10 F. Hoffmann-La Roche Ag Novel benzodioxoles
JP4667867B2 (ja) 2002-08-02 2011-04-13 メルク・シャープ・エンド・ドーム・コーポレイション 置換フロ［２，３−ｂ］ピリジン誘導体
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
MY134457A (en) 2002-11-22 2007-12-31 Merck & Co Inc Substituted amides
JP2006516262A (ja) * 2002-12-17 2006-06-29 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド Ｙ２受容体結合ペプチドの粘膜送達促進のための組成物および方法ならびに肥満症の治療法および予防法
US7186692B2 (en) 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7865595B2 (en) * 2002-12-18 2011-01-04 International Business Machines Corporation Processing call requests with respect to objects
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
WO2004089279A2 (en) * 2003-04-08 2004-10-21 Yeda Research And Development Co. Ltd. Long-acting derivatives of pyy agonists
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
AU2004241242A1 (en) 2003-05-14 2004-12-02 Emisphere Technologies, Inc. Compositions for delivering peptide YY and PYY agonists
WO2005000222A2 (en) 2003-05-30 2005-01-06 Amylin Pharmaceuticals, Inc. Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
US7274740B2 (en) * 2003-06-25 2007-09-25 Sharp Laboratories Of America, Inc. Wireless video transmission system
US20050091693A1 (en) * 2003-10-22 2005-04-28 Rochelle Communications, Inc. Dual mode set-top box that optimizes the delivery and user selection of audio or video programming over data networks
US7151097B2 (en) 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
EP1716137A1 (en) 2004-02-04 2006-11-02 Pfizer Products Incorporated Substituted quinoline compounds
EP1789440A4 (en) * 2004-02-11 2008-03-12 Amylin Pharmaceuticals Inc REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM
US20070244041A1 (en) * 2004-02-23 2007-10-18 Reoscience A/S Peptide Yy Analogues
US7954129B2 (en) * 2004-09-24 2011-05-31 Smartvue Corporation Wireless video surveillance system and method with remote viewing
US20060088105A1 (en) * 2004-10-27 2006-04-27 Bo Shen Method and system for generating multiple transcoded outputs based on a single input
US7620065B2 (en) * 2005-07-22 2009-11-17 Trellia Networks, Inc. Mobile connectivity solution
US8189472B2 (en) * 2005-09-07 2012-05-29 Mcdonald James F Optimizing bandwidth utilization to a subscriber premises

Also Published As

Publication number Publication date
DK1846445T3 (da) 2009-05-04
JP2008528050A (ja) 2008-07-31
CY1109054T1 (el) 2014-07-02
PT1846445E (pt) 2009-05-14
NL1033469A1 (nl) 2007-06-06
SI1846445T1 (sl) 2009-06-30
RS50966B (sr) 2010-10-31
HRP20090245T1 (en) 2009-07-31
AU2006211039A1 (en) 2006-08-10
NO20074498L (no) 2007-11-02
PL1846445T3 (pl) 2009-07-31
PA8660701A1 (es) 2006-09-22
US20060178501A1 (en) 2006-08-10
AP2007004069A0 (en) 2007-08-31
EP2078729A1 (en) 2009-07-15
DOP2006000025A (es) 2006-09-15
TWI310038B (en) 2009-05-21
EA200701439A1 (ru) 2008-02-28
EP1846445A1 (en) 2007-10-24
NL1031067A1 (nl) 2006-08-07
KR100892545B1 (ko) 2009-04-09
US20090170778A1 (en) 2009-07-02
EA011882B1 (ru) 2009-06-30
TNSN07305A1 (fr) 2008-12-31
NL1033469C2 (nl) 2007-10-23
GT200600038A (es) 2006-09-13
ATE426614T1 (de) 2009-04-15
EP1846445B1 (en) 2009-03-25
NL1031067C2 (nl) 2007-03-13
DE602006005902D1 (de) 2009-05-07
ES2322293T3 (es) 2009-06-18
PE20061412A1 (es) 2007-03-08
CA2596977A1 (en) 2006-08-10
AR052108A1 (es) 2007-02-28
WO2006082517A1 (en) 2006-08-10
IL184324A0 (en) 2007-10-31
UY29357A1 (es) 2006-10-02
KR20070094829A (ko) 2007-09-21
MA29243B1 (fr) 2008-02-01
US20090171071A1 (en) 2009-07-02
TW200639180A (en) 2006-11-16
JP4314304B2 (ja) 2009-08-12
CA2596977C (en) 2010-11-02
MX2007009389A (es) 2008-02-12

Similar Documents

Publication Publication Date Title
BRPI0606142A2 (pt) agonistas de pyy e usos dos mesmos
BRPI0509207A (pt) moduladores canabinóides de tetraidro-indazol
BRPI0922597A2 (pt) "ftalazinona e análogos relacionados como moduladores de sirtuína".
UY30319A1 (es) Formulaciones de inhibidores de dpp iv
NO20084368L (no) Stabile emulsjonsformuleringer
BRPI0910557A2 (pt) composições farmacêuticas de paclitaxel, análogos de paclitaxel ou conjugados de paclitaxel e métodos relacionados de preparação e uso.
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
BRPI0905663A2 (pt) "emulsão estável, processo de preparação da emulsão estável e uso emulsão"
MA32257B1 (fr) Hydroxymethyl pyrrolidines comme agonistes des recepteurs beta-3- adrenergiques.
BRPI0910182B8 (pt) composto de fórmula (i), composição farmacêutica e uso de um composto
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
GT200900057A (es) 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-n-metilpiridina-2-carboxamida monohidrato
BR112012020790A2 (pt) anticorpo de neutralização da integrina alfavbeta8
CY1112398T1 (el) Πυρρολιδινονες υποκατασταθεισες απο κυκλοεξυλιο ως αναστολεις της 11-β-υδροξυστεροειδικης αφυδρογονασης 1
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
BRPI0718927A2 (pt) Método de imunização contra os quatro sorotipos da dengue.
BRPI0912928A2 (pt) "composto, e, composição isenta de pirogênio"
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
WO2008013861A3 (en) Screening assay for inhibitors of trpa1 activation by a lower alkyl phenol
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
FR2900209B1 (fr) Dispositif de roulement instrumente
WO2008005407A3 (en) Trace amine-associated receptors in the olfactory epithelium
ATE552832T1 (de) Antidepressivum-propharmaka
EA200970338A2 (ru) Агонисты рецептора еро человека, композиции, способы и применение для предотвращения или лечения состояний, связанных с интолерантностью к глюкозе

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.

B15K Others concerning applications: alteration of classification

Ipc: C07K 14/575 (2006.01), A61K 47/60 (2017.01), A61K